Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Sex Hormones and Fear Inhibition: a Novel Exploration of Why Women Are so Vulnerable to Anxiety Disorders

NCT02622087 is registered in ClinicalTrials.gov with The University of New South Wales as lead sponsor.

NCT NCT02622087
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02622087 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Sex Hormones and Fear Inhibition: a Novel Exploration of Why Women Are so Vulnerable to Anxiety Disorders
Lead sponsor
The University of New South Wales
Phase
Not applicable
Overall status
Completed
Start date
November 30, 2015
Completion date
June 15, 2017
Enrollment
90 (actual)
Sites
1

Conditions

As the registry lists them; a condition with its own page is linked.

phobia, specific